Talking Techniques

Share

CRISPR: developing an equitable technology amidst a global pandemic

Season 1, Ep. 10

In this episode, I speak to Geoffrey Siwo about CRISPR and the challenges facing its development into a technique that can be applied equitably across the globe. Geoffrey talks about the importance of seizing the opportunity to influence the progress of the embryonic gene-editing technology for the better, before the data bias in genomic data and the disparity in researchers working on the technique leads to ingrained differences in the success of the application in different populations. The impact of the COVID-19 pandemic on this development is also exposed.


We also discuss Geoffrey's work, using CISPR in antiviral research to as a way of identifying small molecules capable of inducing broad-spectrum antiviral responses, with the potential to combat SARS-CoV-2.


Tune in to find out how Geoffrey believes we can develop CRISPR to be a truly equitable technology and to hear just how hopeful he is for the future of the technique.


*


The Talking Techniques podcast is hosted and produced by Tristan Free for BioTechniques. We would love to here more from our listeners about your opinions on the podcast, what you would like to hear more of and what you think we could do better!

Please get in contact on any of the platforms below.


Twitter: @TristanFreefsg

Email: tfree@biotechniques.com



More Episodes

3/30/2021

How PCR has prevailed during the COVID-19 pandemic

Season 2, Ep. 5
In Part 3 of our COVID-19 diagnostics and detection miniseries, supported byRoche, we explore the contributionPCRhas made towards diagnosis during the pandemic. Providing me with an insight into the world of PCR diagnostics is Tyler Miller, Clinical Pathology Resident and Research Fellow atMassachusetts General Hospital(MA, USA), where he was instrumental in setting up the testing regimen for the Hospital.Ty details the attributes of PCR that lead to it becoming the gold standard for diagnostic tests, before explaining the variance in clinical detection rate during a patient’s disease course and how this variation correlates with the infectivity of the patient. Ty also delves into the variety of sample collection methods available, how each of these methods compares in terms of sensitivity and their ability to be integrated into exciting novel PCR techniques.We also look at the work of theBroad Institutein establishing a mass testing effort that involved automation, workflow optimization and hundreds of new staff, ultimately leading to the delivery of 100,000 tests a day, almost 5% of the USA’s total COVID-19 testing at the time. All of this rapid work has led to dramatic changes in the PCR technique and process. These changes are perhaps exemplified by PCR testing without RNA extraction and purification, which Ty explains was partly developed due to the limited supplies available to researchers at the beginning of the pandemic.ContentsIntroduction: 00:00-02:00Why PCR tests are so valuable: 02:00-03:10Changes in clinical detection rate and infectivity: 03:10-8:00Infectivity and exceptions to the rule: 08:00-09:00Sample collection methods, sensitivity and encouraging testing uptake 09:00-17:00The Broad Institute’s mass testing regimen: 17:00-21:00Developments during the pandemic and no RNA extraction PCR: 21:00-27:00Dreams for improving COVID-19 testing: 27:00- 30:00This episode was supported byRoche sequencing and life science. Follow these links to find out more about theLightCycler 480System andLightCycler 96 System.
3/25/2021

Reproducibility in microbiomics

Season 2, Ep. 4
Returning to the contentious topic of the Reproducibility crisis –the inability of many study results to be replicated by different research groups or labs –this episode, supported by Zymo Research, zeros in on the topic within the field of microbiomics. Speaking to me about the topic is Raul Cano, Chief Scientific Officer at the BioCollective. Raul discusses the crisis and explains why it is prevalent in the emerging field of microbiomics before taking a look at the key role that microbiomics is beginning to play in the field of diagnostics, and how – if we make changes now – lasting improvements can be made in the field. Raul also lays out the three key areas that are holding back reproducibility in microbiomics and explains the actions that can be taken to improve the situation.Contents:Introduction: 00:00-02:00Explaining the reproducibility crisis: 02:00-02:55How microbiomics compare to other fields in terms of reproducibility: 02:55-04:05Challenges in reproducibility specific to microbiomics: 04:05-05:45The importance of reproducibility in microbiomics: 05:45-07:00Microbiomics in diagnostics: 07:00-10:00 Three key causes of poor reproducibility in microbiomics: 10:00-11:30Is detailed documentation improving in the life sciences? 11:30- 13:00Actions that can improve reproducibility: 13:00-14:15Fecal references: 14:15-16:05The realities of preparing fecal references: 16:05-18:1 5The reception to the new fecal references: 18:15-20:35References vs Standards: 20:35-22:15Standardizing microbiomics data: 22:15-23:20Assessing reproducibility in previous studies: 23:20-25:15Dreams for reproducibility in microbiomics: 25:15-26:55 This episode is supported by Zymo Research. If you would like more information about the fecal reference mentioned in the podcast, you can visit the product page here.